Genmab A/S (GNMSF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 10:20AM EDT. Market open.
| Previous close | 278.34 |
| Open | 295.25 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 284.45 - 295.25 |
| 52-week range | 262.00 - 426.50 |
| Volume | |
| Avg. volume | 1,001 |
| Market cap | 19.054B |
| Beta (5Y monthly) | 0.79 |
| PE ratio (TTM) | 23.70 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript May 2, 2024 Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16. Genmab A/S isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to […]
- GuruFocus.com
Comstock Inc (LODE) Q1 2024 Earnings Call Transcript Highlights: Strategic Investments and ...
Explore key insights from Comstock Inc's Q1 2024 earnings, including significant revenue streams, strategic investments, and future financial strategies.
- Investor's Business Daily
Genmab Takes The Next Step In Its 'Evolution' With A $1.8 Billion Takeover
Genmab stock slumped Wednesday after the Danish biotech announced it will buy privately held ProfoundBio for $1.8 billion.
© 2024 Yahoo. All rights reserved.